Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Science Translational Medicine

• Publication date

  2016-05-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/scitranslmed.aad4059PMID 27225183PMCID PMC8722465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

  2014cited by this paper
• Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia

  2014cited by this paper
• A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype

  2014cited by this paper
• Plenary Paper

  2013cited by this paper
• Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase III trial.

  2013cited by this paper
• Distinct glycosyltransferases synthesize E-selectin ligands in human vs. mouse leukocytes

  2013cited by this paper
• Monitoring apoptosis and Bcl‐2 on circulating tumor cells in patients with metastatic breast cancer

  2013influential reference
• Three to Tango: MUC1 as a Ligand for Both E-Selectin and ICAM-1 in the Breast Cancer Metastatic Cascade

  2012cited by this paper
• The Impact of Peroxisomes on Cellular Aging and Death

  2012cited by this paper
• The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin

  2012cited by this paper
• Bone Marrow Niches for Hematopoietic Stem Cells and Immune Cells

  2012cited by this paper
• Epithelial and Mesenchymal Cell Biology ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells

  2012cited by this paper
• Mac-2 Binding Protein Is a Novel E-Selectin Ligand Expressed by Breast Cancer Cells

  2012cited by this paper
• Circulating tumour cells in non-metastatic breast cancer: a prospective study.

  2012cited by this paper
• E-Selectin Ligands as Mechanosensitive Receptors on Neutrophils in Health and Disease

  2012cited by this paper
• Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy.

  2012cited by this paper
• Selectin-deficiency reduces the number of spontaneous metastases in a xenograft model of human breast cancer.

  2012cited by this paper
• Direct measurements on CD24-mediated rolling of human breast cancer MCF-7 cells on E-selectin.

  2011cited by this paper
• Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells.

  2011cited by this paper
• Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow.

  2011cited by this paper
• Gangliosides expressed on breast cancer cells are E-selectin ligands.

  2011cited by this paper
• Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)

  2010cited by this paper
• The Vote of Acute Medical Inpatients

  2009cited by this paper
• From carbohydrate leads to glycomimetic drugs

  2009influential reference
• Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone.

  2009cited by this paper
• Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

  2009cited by this paper
• Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells

  2009influential reference
• A stromal gene signature associated with inflammatory breast cancer

  2008cited by this paper
• Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton.

  2008cited by this paper
• Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer

  2006cited by this paper
• Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches.

  2006cited by this paper
• Functions of CXCL12 and CXCR4 in breast cancer.

  2006cited by this paper
• Cytokines and hematopoietic stem cell mobilization

  2006cited by this paper
• Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype

  2006cited by this paper
• A pooled analysis of bone marrow micrometastasis in breast cancer.

  2005cited by this paper
• In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment

  2005influential reference
• The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer.

  2005cited by this paper
• Molecular markers of breast cancer metastasis

  2005cited by this paper
• Breast cancer metastasis: markers and models

  2005cited by this paper
• CXCR 4 Regulates Growth of Both Primary and Metastatic Breast Cancer

  2004cited by this paper
• CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer

  2004cited by this paper
• Induction of Syndecan-1 Expression in Stromal Fibroblasts Promotes Proliferation of Human Breast Cancer Cells

  2004cited by this paper
• Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

  2004cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma

  2003cited by this paper
• G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4

  2002cited by this paper
• Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4

  2002cited by this paper
• G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4

  2002cited by this paper
• Circulating breast cancer cells are frequently apoptotic.

  2001influential reference
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• Endothelial and epithelial expression of sialyl Lewisx and sialyl Lewisa in lesions of breast carcinoma

  1997cited by this paper
• Dil and diO: versatile fluorescent dyes for neuronal labelling and pathway tracing.

  1989cited by this paper

• Remodeling the tumor dormancy ecosystem to prevent recurrence and metastasis

  2026cites this paper
• Dormancy and Recurrence in Breast Cancer Bone Metastasis: From Mechanisms to Clinical Translation

  2026cites this paper
• Hematopoietic Niche Hijacking in Bone Metastases: Roles of Megakaryocytes, Erythroid Lineage Cells, and Perivascular Stromal Subsets

  2026cites this paper
• Navigating P-Selectin for Targeted Drug Delivery and Therapeutic Applications in Cancer and Inflammatory Disorders.

  2026cites this paper
• Bone Metastasis: Molecular Mechanisms, Clinical Management, and Therapeutic Targets

  2026cites this paper
• Targeting metastasis with nanomedicine

  2025cites this paper
• Metabolic adaptations in cancer progression.

  2025cites this paper
• Towards deciphering the bone marrow microenvironment with spatial multi-omics.

  2025cites this paper
• Impact of the ECM on the Mechanical Memory of Cancer Cells

  2025cites this paper
• Bioengineered human bone-mimetic niche compositions regulate breast cancer cell quiescence and therapy response

  2025cites this paper
• Microenvironmental and Molecular Pathways Driving Dormancy Escape in Bone Metastases

  2025cites this paper
• The role of the immune tumor microenvironment in shaping metastatic dissemination, dormancy, and outgrowth.

  2025cites this paper
• Single-cell profiling of bone metastasis ecosystems from multiple cancer types reveals convergent and divergent mechanisms of bone colonization

  2025cites this paper
• Clinical applications of circulating tumor cells in metastasis and therapy

  2025cites this paper
• Microenvironmental Regulation of Dormancy in Breast Cancer Metastasis: "An Ally that Changes Allegiances".

  2025cites this paper
• Defining the Tumor-Bone axis: the role of extracellular vesicles in a crucial exchange route for breast cancer development and progression

  2025cites this paper
• Spatiotemporal dynamics of the pre-metastatic niche: remodeling of lung microenvironment before breast cancer metastasis and targeted intervention strategies.

  2025cites this paper
• The Breast to Bone (B2B) Cohort Study to Prevent, Detect and Improve Treatment of Metastatic Disease: Baseline Assessment, Description and Progress

  2025cites this paper
• CXCR4 promotes tumor stemness maintenance and CDK4/6 inhibitors resistance in ER-positive breast cancer

  2025cites this paper
• From breast cancer cell homing to the onset of early bone metastasis: The role of bone (re)modeling in early lesion formation

  2024cites this paper
• Metabolic landscape of disseminated cancer dormancy.

  2024cites this paper
• A Live Tracker of Dormant Disseminated Tumor Cells.

  2024cites this paper
• Mechanistic and Therapeutic Implications of Protein and Lipid Sialylation in Human Diseases

  2024cites this paper
• The osteoblast in regulation of tumor cell dormancy and bone metastasis

  2024cites this paper
• Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors

  2024cites this paper
• Unveiling cancer dormancy: intrinsic mechanisms and extrinsic forces.

  2024cites this paper
• Cancer Cells in Sleep Mode: Wake Them to Eliminate or Keep Them Asleep Forever?

  2024cites this paper
• Molecular mechanism of bone metastasis in breast cancer.

  2024cites this paper
• Bone metastasis in endocrine-related cancer: unravelling invasion and destruction.

  2024cites this paper
• Implication of the Extracellular Matrix in Metastatic Tumor Cell Dormancy

  2024cites this paper
• MAIN WAYS OF THE INITIATION OF CANCER CELL DORMANCY: TGFβ ROLE

  2024cites this paper
• Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease

  2024cites this paper
• Macrophage heterogeneity in bone metastasis

  2024cites this paper
• An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche

  2024cites this paper
• Cell-cell communication characteristics in breast cancer metastasis

  2024cites this paper
• Linking cell mechanical memory and cancer metastasis

  2024cites this paper
• Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of Cancer stem cells

  2024cites this paper
• Single-Cell Analysis of Bone-Marrow-Disseminated Tumour Cells

  2024cites this paper
• Immune mediated support of metastasis: Implication for bone invasion

  2024cites this paper
• Bone serves as a transfer station for secondary dissemination of breast cancer

  2023influential citation
• Regulation of dormancy during tumor dissemination: the role of the ECM

  2023cites this paper
• Metastasis prevention: How to catch metastatic seeds.

  2023cites this paper
• Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians

  2023cites this paper
• The Role of Cytokines in the Metastasis of Solid Tumors to the Spine: Systematic Review

  2023cites this paper
• Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal.

  2023cites this paper
• Role of myeloid-derived suppressor cells in tumor recurrence

  2023cites this paper
• Dynamic bioinspired coculture model for probing ER+ breast cancer dormancy in the bone marrow niche

  2023cites this paper
• From breast cancer cell homing to the onset of early bone metastasis: dynamic bone (re)modeling as a driver of metastasis

  2023cites this paper
• The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients

  2023cites this paper
• Single-cell transcriptomics provide insight into metastasis-related subsets of breast cancer

  2023cites this paper
• Bone marrow vasculature advanced in vitro models for cancer and cardiovascular research

  2023cites this paper
• Associations amongst genes, molecules, cells, and organs in breast cancer metastasis

  2023cites this paper
• Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions

  2023cites this paper
• From breast cancer cell homing to the onset of early bone metastasis: dynamic bone (re)modeling as a driver of osteolytic disease

  2023cites this paper
• Qilian Formula Inhibits Tumor Cell Growth in a Bone Metastasis Model of Lung Cancer

  2023cites this paper
• MicroRNAs: Emerging Regulators of Metastatic Bone Disease in Breast Cancer

  2022cites this paper
• Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment

  2022cites this paper
• Chemokines network in bone metastasis: Vital regulators of seeding and soiling.

  2022cites this paper
• The prospect of tumor microenvironment-modulating therapeutical strategies

  2022cites this paper
• Bone niche and bone metastases

  2022cites this paper
• Extracellular vesicle cargo metabolome changes in response to the mesenchymal stromal cell microenvironment and influences cell quiescence and activation in a human breast cancer cell model

  2022cites this paper
• MicroRNAs and bone metastasis

  2022cites this paper
• Response of the Bone Marrow Stem Cells and the Microenvironment to Stress

  2022cites this paper
• Viscoelastic Liquid Matrix with Faster Bulk Relaxation Time Reinforces the Cell Cycle Arrest Induction of the Breast Cancer Cells via Oxidative Stress

  2022cites this paper
• Breast Cancer Metastatic Dormancy and Relapse: An Enigma of Microenvironment(s)

  2022cites this paper
• Dormancy: There and Back Again

  2022cites this paper
• Dormancy in cancer bone metastasis

  2022cites this paper
• Bone metastasis initiation is coupled with bone remodeling through osteogenic differentiation of NG2+ cells.

  2022cites this paper
• Insights into the Role of Sialylation in Cancer Metastasis, Immunity, and Therapeutic Opportunity

  2022cites this paper
• Osteoblastic protein kinase D1 contributes to the prostate cancer cells dormancy via GAS6-circadian clock signaling.

  2022cites this paper
• Lipopolysaccharide sensitizes the therapeutic response of breast cancer to IAP antagonist

  2022cites this paper
• Aberrant Sialylation in Cancer: Therapeutic Opportunities

  2022cites this paper
• Principles of dormancy evident in high-grade serous ovarian cancer

  2022cites this paper
• Ecology and evolution of dormant metastasis.

  2022cites this paper
• Mechanisms of Cell Adhesion Molecules in Endocrine-Related Cancers: A Concise Outlook

  2022cites this paper
• Tumor Dormancy: Biologic and Therapeutic Implications

  2022cites this paper
• Dormancy: There and Back Again

  2022influential citation
• Targeting Metastatic Cancer: Disseminated Tumor Cells and Premetastatic Niches

  2022cites this paper
• Glycosylation as a regulator of site-specific metastasis

  2021cites this paper
• Osteolytic effects of tumoral estrogen signaling in an estrogen receptor-positive breast cancer bone metastasis model

  2021cites this paper
• Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy

  2021cites this paper
• Targeting E-selectin to Tackle Cancer Using Uproleselan

  2021cites this paper
• Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis

  2021cites this paper
• Leukaemia: a model metastatic disease

  2021cites this paper
• Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells

  2021cites this paper
• Mechanisms, Diagnosis and Treatment of Bone Metastases

  2021cites this paper
• Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain

  2021cites this paper
• The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans

  2021cites this paper
• Exploiting bone niches: progression of disseminated tumor cells to metastasis.

  2021cites this paper
• Targeting Histone Modifications in Bone and Lung Metastatic Cancers

  2021cites this paper
• Role of miRNAs in Breast Cancer-induced Bone Disease

  2021cites this paper
• Could Extracellular Vesicles Contribute to Generation or Awakening of “Sleepy” Metastatic Niches?

  2021cites this paper
• Breast cancer–secreted factors perturb murine bone growth in regions prone to metastasis

  2021cites this paper
• Redox Control of the Dormant Cancer Cell Life Cycle

  2021cites this paper
• Evolving cancer–niche interactions and therapeutic targets during bone metastasis

  2021cites this paper
• Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways

  2021cites this paper
• Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging

  2021cites this paper
• Long-term outcome of (neo)adjuvant zoledronic acid therapy in locally advanced breast cancer

  2021cites this paper
• Establish a Prediction Model for the Recurrence Time of Hormone Receptor Positive /human Epidermal Growth Factor Receptor 2-negative Breast Cancer

  2021cites this paper
• Thorny ground, rocky soil: tissue-specific mechanisms of tumor dormancy and relapse.

  2021cites this paper